Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 studyXinxin Cao, Daobin Zhou, Chengcheng Fu et al.|EClinicalMedicine|2022Cited by 43